BLRX BioLineRx Ltd
Company Analysis
Latest News
🟢 BioLineRx is trading 6.3% up today as September rate expectations support growth stocks
BioLineRx is trading 6.3% up now at $2.87 amid a broader risk-on session, as softer-than-expected July producer inflation and slightly higher jobless claims...
🟢 BioLineRx is trading 8.75% up today ahead of estimated August 13, 2026 Q2 earnings
BioLineRx is trading 8.75% up now at $3.00, as investors may also be positioning ahead of the estimated August 13, 2026 Q2 earnings release. - The stock...
BioLineRx Ltd Q2 2026 Earnings Preview: What Analysts Expect on August 13, 2026
BioLineRx is expected to report a Q2 2026 loss of $0.02 per share on revenue of $8.45 million, while the current stock price of $1.15 remains significantly...
🟢 BioLineRx is trading 16.91% up in pre-market — catalyst unconfirmed
BioLineRx is trading at $3.25, up 16.91%, with the catalyst unconfirmed. - The stock rose from its August 6 close of $2.79; searches found no clear...
🟢 BioLineRx is trading 7.9% up today as biotech sector rally continues
BioLineRx is trading at $2.95 (up 7.9%), extending its recent rebound amid a broader biotech sector rally and risk-on market sentiment. • The move follows a...
🟢 BioLineRx is trading 5.9% up today amid broad risk-on sentiment in the biotech sector
BioLineRx is trading at $2.81 (+5.85%) as shares move higher amid broad risk-on sentiment and a positive tone across the biotech sector. • The stock is...
🟢 BioLineRx is trading 5.3% up today in after-hours trading with no clear catalyst yet
BioLineRx is trading 5.3% higher at $2.79 in after-hours trading, recovering from a regular-session decline despite no new company-specific filings or news...
🔴 BioLineRx is trading 5.7% down today despite no fresh company news
BioLineRx is trading 5.7% down at $2.63 today, despite a lack of fresh company-specific news or regulatory filings to explain the move. • The decline follows...
🟢 BioLineRx is trading 7.8% up today on no clear news
BioLineRx is trading 7.8% up at $3.04 on no clear news, appearing to move on idiosyncratic trading or a low-float swing. • No company-specific catalysts were...
🟢 BioLineRx is trading 6.5% up today on continued momentum from recent licensing and financing deals
BioLineRx is trading 6.5% up at $3.02 on continued momentum from recent licensing and financing deals. • Sentiment remains supported by a recent licensing...
🔴 BioLineRx is trading 5.8% down today on sector-wide risk-off sentiment
BioLineRx is trading 5.8% down at $2.92 today as the stock gives back recent gains amid a broader biotechnology sector pullback. • The decline aligns with...
🔴 BioLineRx is trading 7.7% down today on profit-taking and broader biotech volatility
BioLineRx is trading 7.7% down at $2.86 in pre-market action, pulling back as investors lock in profits following recent gains in the clinical-stage biopharma...
BioLineRx Drops 11% on a Risk-Off Day — Can Promising Cancer Data Overcome Small-Cap Biotech's Credibility Problem?
Shares of BioLineRx slid 11% to $2.81 in early trading July 8, erasing gains the Israeli biotech had built over the prior week, as a broad retreat from riskier...
🔴 BLRX is trading 11% down today as risk-off sentiment offsets positive GLIX1 data
BLRX is trading 11% down at $2.81 as broader market weakness and risk-off sentiment in the small-cap biotech sector outweigh positive clinical news. •...
🔴 BLRX Dips 12.03% Amid Broader Market Sell-Off, BioLineRx Announces Positive GLIX1 Preclinical Data in Ovarian Cancer
• BLRX is trading at $2.78, down 12.03% from yesterday's close, as broader market risk-off sentiment impacts stocks. • This decline comes despite BioLineRx...